Breast cancer survivors optimistic, yet lack critical information on reducing recurrenceSeptember 26, 2007The majority of breast cancer survivors consider themselves stronger after having the disease, according to new survey results released today. However, the data also suggest women's knowledge about actions they can take to lessen the likelihood of recurrence is surprisingly low. The survey, which was commissioned by AstraZeneca and conducted by Harris Interactive, consisted of interviews with 543 women in the United States who had been diagnosed with breast cancer. The vast majority (92 percent) of these women reported a positive change in their lifestyles since being diagnosed with the disease and nearly two-thirds (63 percent) said they are hopeful and optimistic about the future. Nearly nine in 10 (87 percent) said that having breast cancer made them a stronger person and about four in five (83 percent) said they were better able to put their lives in perspective. Due to the significant focus on early detection and recent medical and scientific advances, women are surviving breast cancer, remaining disease-free and living longer and healthier lives. The survey also showed that breast cancer survivors are more likely to identify a great deal with other women who have had the disease (66 percent) than with people of the same ethnic/racial background (41 percent) or religious beliefs (40 percent). The survivorship community continues to flourish with more than 2.3 million breast cancer survivors in the U.S. today, making this the largest group of cancer survivors. Interestingly, the same survey results also suggest that there may be a "disconnect" with information regarding the chances of breast cancer returning. While the majority (78 percent) of women who have had breast cancer are concerned about recurrence, 30 percent don't believe and 23 percent aren't sure there is anything they can do to lessen the likelihood of a breast cancer recurrence and only about half (55 percent) have spoken to their doctor about recurrence. The survey suggests that more action and education is needed about the many ways, such as healthier eating, reducing stress and taking hormonal therapy, women can help reduce the risk of recurrence. "For most women, a diagnosis of breast cancer has a significant impact on their lifestyle and the way they monitor their health. We want to support all women who have had breast cancer in getting the best information available to help them remain disease-free for as long as possible," said Jean A. Sachs, MSS, MLSP, executive director of Living Beyond Breast Cancer, a nonprofit organization based outside of Philadelphia. "We strongly encourage women who have had breast cancer and their loved ones to speak with their health care professionals to obtain the facts." According to the survey, more breast cancer survivors (72 percent) said they relied heavily on their doctors or health professionals in their path to recovery than said they relied on either friends (67 percent) or spouse (52 percent). The majority of respondents, 89 percent, said that they are somewhat involved/not involved in a breast cancer survivor community, and thus might lack the support and access to timely information that they need. The majority (87 percent) of breast cancer survivors surveyed said having the disease made them a stronger person, and 63 percent of all respondents are hopeful and optimistic about the future. Edelman Public Relations |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||